News

Export from Switzerland

Invest in Switzerland

About S-GE

Neurosoft’s recent achievements set the stage for innovative treatment methods and heightened diagnostic capabilities for severe neurological disorders.

Neurosoft Bioelectronics, headquartered at Campus Biotech in Geneva, has successfully conducted a groundbreaking human trial of its stretchable h...

Backed by its parent company Nanobacterie's fourth-place in nanomedicine patent rankings by Marks and Clerk, AlphaOnco Swiss channels the synergy of Franco-Swiss collaboration to bring forth groundbreaking cancer treatments.

Drawing from the achievements of its parent company, Nanobacterie, Valais-based AlphaOnco Swiss stands at the forefront of innovative nanomedicin...

The Pôle Santé campus will bring together the expertise of the HES-SO Valais-Wallis, EPFL, The Ark Foundation, the Valais Health Observatory and SpArk, the center of excellence for movement science and technology.

Valued at CHF 86 million, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in the healthca...

Replacing the main building constructed in 1970, the Anna-Seiler-Haus stands out as one of Switzerland’s most advanced and appealing hospital buildings.

On 17 August 2023, the canton of Bern celebrated a new chapter in healthcare advancement with the inauguration of the Anna-Seiler-Haus, the new m...

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs healthy controls. The blue-to-white color scale indicates more pronounced tau loads, with pink-white areas representing those with the highest accumulation.

HUG and UNIGE’s tau PET imaging offers a transformative leap in Alzheimer’s diagnosis, promising early detection and brighter futures for million...

The canton of Bern, with its continual focus on advancing medicine through research, technology, and collaboration, stands as destination rich in opportunities for companies aiming to grow and innovate in the fields of medicine and life sciences.

In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.

This discovery provides insight into the complex ecosystem of the tumor microenvironment and offers a new perspective on the treatment of cancer, particularly in the field of oncology.

A groundbreaking discovery by a team from the University of Geneva could pave the way for targeted cancer treatments by revealing how two key gen...

EPITERNA focuses on developing therapies that can extend the healthy lifespan of companion dogs, cats, and humans.

Vaud-based longevity start-up EPITERNA has secured EUR 10 million in funding from Prima Materia, an investment firm founded by Spotify founder Da...

Over the years, the >>venture>> Awards have served as a crucial platform for startups, offering them a valuable opportunity to showcase their innovations, gain exposure, and receive non-dilutive funding and business consulting services.

The prestigious >>venture>> competition, Switzerland’s leading start-up contest, yielded remarkable results for Western Switzerland start-ups Bea...

InSphero

Discover how you can benefit from Switzerland's strong investor base and several accelerator programs to support the launch and growth of your li...

lab and clipboard, science

Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...

st. gallen Lab

Are you looking for skilled personnel in the Life Science industry? Switzerland is famous for its highly qualified workforce. Find out how your L...

Start-ups WattAnyWhere, Enhance-d, and Neur.on win big in global awards thanks to their pioneering technologies in cleantech, healthcare, and legal tech respectively.

Start-ups WattAnyWhere, Enhance-d, and Neur.on win big in global awards thanks to their pioneering technologies in cleantech, healthcare, and leg...

From left to right. Mélanie Stäuble (Master student), Denis Prim (Diagnostic Systems laboratory manager), David Tagan, Marc Pignat, Marc Pfeifer (Diagnostic Systems research group manager), Isaline Torche (Bachelor student), Steve Gallay (microelectronics laboratory manager), Milica Jovic. | © HES-SO Valais-Wallis, Laurent Darbellay

Axe Santé, an interdisciplinary health technology development center, serves as a hub that unifies all the research institutes of the HES-SO Vala...

Originally based in Neuchâtel, CSEM’s digital health research department will be relocated to Bern.

CSEM’s digital health research department will be relocated to Bern, marking an important milestone in the expansion of digital health research i...

Moderna’s mRNA vaccine for melanoma will be tested at the Geneva University Hospitals in 2023. The vaccine, combined with immunotherapy, could significantly reduce cancer recurrence.

Moderna's mRNA vaccine for melanoma will be tested at the Geneva University Hospitals in 2023. The vaccine, combined with immunotherapy, could si...

This achievement promises to revolutionize treatment approaches and may also pave the way for new therapeutic avenues for other cancer types.

In an exciting turn of events in the world of cancer therapy, researchers from the University of Bern, Inselspital Bern, and the University of Co...

novartis campus

Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...

Official program

Export
Invest

Caroline Blaser

Caroline Blaser

Head of Swiss Business Hub USA